Experts at the Brain Tumor Center are the First in U.S. to Use Targeted GammaTile Therapy for Patients with Newly Diagnosed Malignant Brain Tumors
OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders
February 26, 2020
OHC, Mayfield Brain & Spine and The Jewish Hospital – Mercy Health continued to evolve the standard of care for brain tumors last month when they became the first team in the United States to utilize GammaTile Therapy for the treatment of newly... Read More
OHC Offers Hope for Patients with Cancerous Brain Tumors
Elizabeth H. Levick, MD, radiation oncologist with OHC
February 20, 2020
Despite the odds for patients diagnosed with a cancerous brain tumor, OHC is offering these patients a fighting chance with more targeted techniques of delivering radiation and help with side effects. The five-year survival rate for patients with a... Read More
Patient Follows Through on a Hunch and Gets Expert Help From OHC for Cervical Cancer
OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders
February 13, 2020
Charlene Crank always took good care of her health. Then, about five years ago, she began having problems related to her thyroid and menopause. While working with her primary care doctor to manage these health issues, she paid less attention to other... Read More
OHC was the first independent adult cancer group in the region to bring the ground-breaking CAR T-cell therapy to adults with blood cancers. It’s been more than a year, so is this approach to treatment here to stay?
OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders
February 13, 2020
In 2018, OHC was the region’s first adult cancer group to offer chimeric antigen receptor T-cell therapy (CAR-T) to adults with blood cancers. This was a ground-breaking moment in the history of worldwide cancer care and OHC was at the forefront.... Read More
OHC is Giving Hope to Patients With Gallbladder and Bile Duct Cancer
Kurt P. Leuenberger, MD, medical oncologist and hematologist at OHC who specializes in gastrointestinal cancers
February 10, 2020
February is Gallbladder and Bile Duct Cancer Awareness Month and OHC is giving patients a fighting chance as the only independent cancer group in Ohio to offer a clinical trial for a new treatment for bile duct cancer. The good news about gallbladder... Read More
Every year, Cincinnati magazine issues their Top Docs edition, which lists those doctors voted by other doctors as the top in their field of medicine. OHC once again dominated the three cancer categories. The following OHC doctor are included in the... Read More
OHC Helps You Determine Which Cancer Screenings You Should Have and How Often
OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders
January 24, 2020
Screenings save lives. They can find diseases early, before you have symptoms, when they’re easier to treat. At OHC, we know that getting the right screening test at the right time is one of the most important things we can do for our health.... Read More
OHC Researchers Continue Their Quest to Find New Treatments for Advanced Breast Cancer
Prasad R. Kudalkar, MD, medical oncologist and hematologist
January 23, 2020
Cancer researchers at OHC are offering new hope for patients with advanced breast cancer that has not responded to current treatment options or is inoperable. Sometimes the cells in a breast have a gene that has been altered, called a mutation. This... Read More
On Saturday, January 11, OHC’s team of medical, radiation and gynecologic oncology doctors invited all OHC employees to a special celebration to express their gratitude for the exceptional care and compassion they surround patients and their family... Read More
OHC Gynecology Oncologist Reports Decrease in HPV – the Primary Source of Cervical Cancer
OHC, Specialists in the Treatment of Adult Cancers and Blood Disorders
January 10, 2020
January is Cervical Cancer Awareness Month, and OHC is pleased to share that the primary source of cervical cancer – the HPV virus – has decreased since the introduction of the vaccine, Gardasil. “It’s been almost 15 years since Gardasil was... Read More
